DegnanM, MousaSA. A narrative review of buprenorphine in adult cancer pain. Expert Rev Clin Pharmacol, 2020; 13(10):1159–1167; doi: 10.1080/17512433.2020.1822163
2.
CheckDK, SonejiS, CohenHJ, et al.Association of opioid and benzodiazepine coprescribing with adverse events among older adults with cancer. J Natl Cancer Inst, 2025; 117(7):1465–1473; doi: 10.1093/jnci/djaf072
3.
ChwistekM, SherryD, KinczewskiL, et al.Should buprenorphine be considered a first-line opioid for the treatment of moderate to severe cancer pain? J Pain Symptom Manage, 2023; 66(5):e638–e643; doi: 10.1016/j.jpainsymman.2023.06.022
4.
BeckerWC, SealKH, NelsonDB, et al.; VOICE Study Group. Buprenorphine, pain, and opioid use in patients taking high-dose long-term opioids: A randomized clinical trial. JAMA Intern Med, 2025; 185(4):372–381; doi: 10.1001/jamainternmed.2024.8361
